There are 2949 resources available
Introduction
Presenter: Luca Quagliata
Session: Thermo Fisher Scientific - NGS Biomarker testing: Time matters . No longer need to wait for weeks, as this can now happen within days
Resources:
Webcast
Genomic profiling is driving the precision oncology
Presenter: Philip Jermann
Session: Thermo Fisher Scientific - NGS Biomarker testing: Time matters . No longer need to wait for weeks, as this can now happen within days
Resources:
Webcast
Lung cancer diagnostic test needs: perspective from a thoracic oncologist
Presenter: Gabriela Fernandes
Session: Thermo Fisher Scientific - NGS Biomarker testing: Time matters . No longer need to wait for weeks, as this can now happen within days
Resources:
Webcast
Establishment of a large-scale Asian genomic screening platform to identify non-small cell lung cancer with rare driver oncogenes and clarify drug resistant mechanisms
Presenter: Koichi Goto
Session: Thermo Fisher Scientific - NGS Biomarker testing: Time matters . No longer need to wait for weeks, as this can now happen within days
Resources:
Webcast
NTRK, RET and other fusion biomarkers testing: Latest developments
Presenter: Philip Jermann
Session: Thermo Fisher Scientific - NGS Biomarker testing: Time matters . No longer need to wait for weeks, as this can now happen within days
Resources:
Webcast
Welcome and introduction
Presenter: Neal Shore
Session: PeerVoice - Extending overall survival in nmCRPC while maintaining quality of life: Can we have it all?
Resources:
Webcast
Understanding the current landscape: Insights from clinical practice
Presenter: Thomas Yau
Session: Ipsen - The today and tomorrow of systemic treatment for HCC
Resources:
Webcast
How data could shape the future of clinical practice
Presenter: Lorenza Rimassa
Session: Ipsen - The today and tomorrow of systemic treatment for HCC
Resources:
Webcast
Close
Presenter: Peter Galle
Session: Ipsen - The today and tomorrow of systemic treatment for HCC
Resources:
Webcast
Welcome and introduction
Presenter: Tanja Cufer
Session: Boehringer Ingelheim - Focus on NSCLC treatment options
Resources:
Webcast